ConductScience.org, home

Paper40947993

Prospective Comparative Evaluation of the Xpert MTB/RIF and Xpert MTB/RIF Ultra Assays for Detecting Mycobacterium tuberculosis and Rifampin Resistance in High-resource, Intermediate-burden Settings.

Suh E and 6 others. Ann Lab Med, 2025. Cited by 1 paper, by iCite.

Cite this record

ConductScience Library. Prospective Comparative Evaluation of the Xpert MTB/RIF and Xpert MTB/RIF Ultra Assays for Detecting Mycobacterium tuberculosis and Rifampin Resistance in High-resource, Intermediate-burden Settings. Papers, record 40947993. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40947993

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Prospective Comparative Evaluation of the Xpert MTB/RIF and Xpert MTB/RIF Ultra Assays for Detecting Mycobacterium tuberculosis and Rifampin Resistance in High-resource, Intermediate-burden Settings.
PubMed
Journal
Ann Lab Med
PubMed
Year
2025
PubMed
Publication types
Journal Article, Comparative Study, Evaluation Study
PubMed
Citations, by iCite
1
iCite
Revised in PubMed
2025-10-22
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Mycobacterium tuberculosisMajor topic
RifampinMajor topic
Drug Resistance, BacterialMajor topic
TuberculosisMajor topic
Humans
Prospective Studies
Sensitivity and Specificity
DNA-Directed RNA Polymerases
Mutation
Bacterial Proteins
DNA, Bacterial
Antibiotics, Antitubercular
Microbial Sensitivity Tests

Source PubMed

Download CSV of topics

References25

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
137787077Evidence for Tuberculosis in Individuals With Xpert Ultra "Trace" Sputum During Screening of High-Burden Communities.Clin Infect Dis2024https://conductscience.org/library/papers/37787077PubMed
210764337
Diagnostic Standards and Classification of Tuberculosis in Adults and Children. This official statement of the American Thoracic Society and the Centers for Disease Control and Prevention was adopted by the ATS Board of Directors, July 1999. This statement was endorsed by the Council of the Infectious Disease Society of America, September 1999.
Am J Respir Crit Care Med2000https://conductscience.org/library/papers/10764337PubMed
331173647Xpert MTB/RIF and Xpert MTB/RIF Ultra for pulmonary tuberculosis and rifampicin resistance in adults.Cochrane Database Syst Rev2019https://conductscience.org/library/papers/31173647PubMed
437452349GeneXpert MTB/RIF Ultra performance to detect uncommon rpoB mutations in Mycobacterium tuberculosis.BMC Res Notes2023https://conductscience.org/library/papers/37452349PubMed
535471095Diagnostic Performance of Xpert MTB/RIF Ultra Compared with Predecessor Test, Xpert MTB/RIF, in a Low TB Incidence Setting: a Retrospective Service Evaluation.Microbiol Spectr2022https://conductscience.org/library/papers/35471095PubMed
636602360Performance Evaluation of the BACTEC MGIT 960 System for Rifampin Drug-Susceptibility Testing of Mycobacterium tuberculosis Using the Current WHO Critical Concentration.J Clin Microbiol2023https://conductscience.org/library/papers/36602360PubMed
730728191Heat Inactivation Renders Sputum Safe and Preserves Mycobacterium tuberculosis RNA for Downstream Molecular Tests.J Clin Microbiol2019https://conductscience.org/library/papers/30728191PubMed
835876568The Practical Value of Xpert MTB/RIF Ultra for Diagnosis of Pulmonary Tuberculosis in a High Tuberculosis Burden Setting: a Prospective Multicenter Diagnostic Accuracy Study.Microbiol Spectr2022https://conductscience.org/library/papers/35876568PubMed
922779067Rapid diagnosis of tuberculosis and multidrug resistance using a MGIT 960 system.Ann Lab Med2012https://conductscience.org/library/papers/22779067PubMed
1028851844The New Xpert MTB/RIF Ultra: Improving Detection of Mycobacterium tuberculosis and Resistance to Rifampin in an Assay Suitable for Point-of-Care Testing.mBio2017https://conductscience.org/library/papers/28851844PubMed
1133616229Xpert Ultra versus Xpert MTB/RIF for pulmonary tuberculosis and rifampicin resistance in adults with presumptive pulmonary tuberculosis.Cochrane Database Syst Rev2021https://conductscience.org/library/papers/33616229PubMed
1212354807The efficacy of the heat killing of Mycobacterium tuberculosis.J Clin Pathol2002https://conductscience.org/library/papers/12354807PubMed
1332619114Head-to-head comparison of the diagnostic accuracy of Xpert MTB/RIF and Xpert MTB/RIF Ultra for tuberculosis: a meta-analysis.Infect Dis (Lond)2020https://conductscience.org/library/papers/32619114PubMed
1439832887Real-world clinical utility of Xpert MTB/RIF Ultra in the assessment of tuberculosis in a low-TB-incidence, high-resource setting.BMJ Open Respir Res2025https://conductscience.org/library/papers/39832887PubMed
1533130504Performance of Xpert MTB/RIF Ultra assay on respiratory and extra-respiratory samples in a high-resource setting with a low tuberculosis prevalence.Diagn Microbiol Infect Dis2021https://conductscience.org/library/papers/33130504PubMed
1633317678Systematic rifampicin resistance errors with Xpert® MTB/RIF Ultra: implications for regulation of genotypic assays.Int J Tuberc Lung Dis2020https://conductscience.org/library/papers/33317678PubMed
1720825313Rapid molecular detection of tuberculosis and rifampin resistance.N Engl J Med2010https://conductscience.org/library/papers/20825313PubMed
1830928564The rapid molecular test Xpert MTB/RIF ultra: towards improved tuberculosis diagnosis and rifampicin resistance detection.Clin Microbiol Infect2019https://conductscience.org/library/papers/30928564PubMed
1939754613Diagnostic accuracy of Xpert MTB/RIF Ultra for detecting pulmonary tuberculosis and rifampicin resistance: a systematic review and meta-analysis.Eur J Clin Microbiol Infect Dis2025https://conductscience.org/library/papers/39754613PubMed
2024819214Mycobacterium tuberculosis persistence in various adipose depots of infected mice and the effect of anti-tubercular therapy.Microbes Infect2014https://conductscience.org/library/papers/24819214PubMed

See all 25 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.

PMIDTitleJournalYearIn Papers
42219539Bridging Genotypic and Phenotypic Drug Susceptibility Testing for Mycobacterium tuberculosis: A Baseline Prior to the Widespread Use of New and Repurposed Anti-Tuberculosis Drugs.Ann Lab Med2026https://conductscience.org/library/papers/42219539

Source PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40947993

GET https://conductscience.org/api/papers/v1/40947993/references?page=2